In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
no speaker photo
Hugo Katus

University Hospital of Heidelberg, Heidelberg (Germany)

Specialities : Acute Coronary Syndromes , Acute Heart Failure, Chronic Heart Failure, Interventional Cardiology

Write your personal quote here ...

Prof. Hugo A Katus is Professor of Internal Medicine, Director of the Department of Internal Medicine III (Cardiology, Angiology, Pneumology) and Head of Internal Medicine at the University of Heidelberg in Germany. He is also Head of Cardiology at two affiliated hospitals in the Heidelberg area. He is chairing the German Center for Cardiovascular Research Heidelberg/Mannheim (DZHK) and served as Speaker of the National Genome Research Network (NGFN). Prof. Katus was founder and director of the Academy of German Cardiac Society and is the now the Past-President of German Cardiac Society. Prof Katus invented the cardiac troponin T assay, for which he holds a patent jointly with Roche Diagnostics. This invention changed practice of cardiology. In addition to his research interest in cardiac biomarkers he focused on molecular and genetic causes of cardiomyopathies and promoted in the translation of novel diagnostic and therapeutic strategies in heart failure. He is Co-Founder of InoCar

6 presentations from this speaker

Discussant review - HiSTORIC

Congress : ESC Congress 2019

  • Session : Hot Line Session 2
  • Speaker : H Katus (Heidelberg,DE)

Caveats in the implementation of fast diagnostic algorithms for ACS

Congress : ESC Congress 2018

  • Session : The advantages and caveats of fast diagnostic algorithms for suspected NSTE-ACS
  • Speaker : H Katus (Heidelberg,DE)

The future of risk scoring is in biomarkers!

Congress : ESC Congress 2018

  • Session : The value of risk scores for assessment in acute coronary syndrome
  • Speaker : H Katus (Heidelberg,DE)

Cardiac troponin in chest pain patients

Congress : ESC Congress 2017

  • Session : Interpreting cardiac troponin
  • Speaker : H A Katus (Heidelberg,DE)

Introduction - How to use biomarkers to optimize diagnosis and risk stratification of ACS.

Congress : ESC Congress 2017

  • Session : How to use biomarkers to optimize diagnosis and risk stratification of acute coronary syndrome (ACS)
  • Speaker : H A Katus (Heidelberg,DE), C E Mueller (Basel,CH)
  • Sponsored by Roche Diagnostics International

Heart failure: personalisation beyond aetiology and left ventricular function.

Congress : ESC Congress 2013

  • Session : Towards a more personalised cardiology: outcomes of an ESC workshop. The role of 'personalised medicine' in...
  • Speaker : H A Katus (Heidelberg,DE)

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are